naltrexone has been researched along with Insulin Sensitivity in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Choubey, A; Ghosh, D; Girdhar, K; Kar, AK; Kushwaha, S; Mondal, P; Yadav, MK | 1 |
| Chatzis, P; Dinas, K; Makris, V; Pratilas, GC; Sotiriadis, A; Tziomalos, K | 1 |
| Borsook, D; Elman, I; Langleben, DD; Simonson, DC; Swift, R; Taveira, TH; Tschibelu, E; Wu, WC; Yamamoto, R | 1 |
| Brown, WA; Man Lee, CC; Oldfield, BJ; Stefanidis, A | 1 |
| Gwinn, KM; Hurren, KM; Makowski, CT | 1 |
| Barini, A; Cento, RM; Cucinelli, F; Lanzone, A; Mancuso, S; Perri, C; Soranna, L | 1 |
| Guido, M; Lanzone, A; Romualdi, D | 1 |
| Alba, F; Candía, M; Castillo, T; Cipriano, A; Devoto, L; López, G; Sir, T | 1 |
| Leyendecker, G; Rabenbauer, B; Sir-Petermann, T; Waibel-Treber, S; Wildt, L | 1 |
| Caruso, A; Ciampelli, M; Fulghesu, AM; Guido, M; Lanzone, A; Mancuso, S; Murgia, F | 1 |
| Bersi, C; Fruzzetti, F; Genazzani, AR; Parrini, D; Ricci, C | 1 |
| Bittle, JB; Givens, JR; Howes, JF; Karas, JG; Kitabchi, AE; Kurtz, BR; Mitchell, JA | 1 |
3 review(s) available for naltrexone and Insulin Sensitivity
| Article | Year |
|---|---|
The Role of Antiobesity Agents in the Management of Polycystic Ovary Syndrome.
Topics: Androgens; Anti-Obesity Agents; Bupropion; Drug Combinations; Female; Humans; Insulin Resistance; Liraglutide; Naltrexone; Obesity; Orlistat; Polycystic Ovary Syndrome; Weight Loss | 2018 |
Naltrexone/bupropion: an investigational combination for weight loss and maintenance.
Topics: Anti-Obesity Agents; Bupropion; Diabetes Mellitus; Drug Therapy, Combination; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipids; Naltrexone; Obesity; Quality of Life; Waist Circumference; Weight Loss | 2011 |
Role of opioid antagonists in the treatment of women with glucoregulation abnormalities.
Topics: Clinical Trials as Topic; Endorphins; Female; Humans; Hyperinsulinism; Insulin Resistance; Menopause; Naloxone; Naltrexone; Narcotic Antagonists; Obesity; Polycystic Ovary Syndrome | 2006 |
4 trial(s) available for naltrexone and Insulin Sensitivity
| Article | Year |
|---|---|
The effect of naltrexone on body fat mass in olanzapine-treated schizophrenic or schizoaffective patients: a randomized double-blind placebo-controlled pilot study.
Topics: Adipose Tissue; Adult; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Double-Blind Method; Female; Humans; Insulin Resistance; Lipids; Liver Function Tests; Male; Middle Aged; Naltrexone; Olanzapine; Pilot Projects; Psychotic Disorders; Schizophrenia; Young Adult | 2014 |
Use of naltrexone in postmenopausal women with exaggerated insulin secretion: a pilot study.
Topics: Blood Glucose; C-Peptide; Fasting; Female; Glucose; Glucose Tolerance Test; Humans; Hyperinsulinism; Insulin; Insulin Resistance; Middle Aged; Naltrexone; Narcotic Antagonists; Pilot Projects; Postmenopause; Treatment Outcome | 2004 |
Effect of long-term naltrexone treatment on endocrine profile, clinical features, and insulin sensitivity in obese women with polycystic ovary syndrome.
Topics: Adult; Androgens; Blood Glucose; Body Mass Index; Drug Administration Schedule; Endocrine Glands; Fasting; Female; Gonadotropins; Humans; Hydrocortisone; Insulin; Insulin Resistance; Menstrual Cycle; Naltrexone; Narcotic Antagonists; Obesity; Polycystic Ovary Syndrome; Time Factors | 2002 |
Reduction of hyperinsulinemia and insulin resistance by opiate receptor blockade in the polycystic ovary syndrome with acanthosis nigricans.
Topics: Acanthosis Nigricans; Adolescent; Adult; Blood Glucose; Female; Humans; Insulin; Insulin Resistance; Naloxone; Naltrexone; Narcotic Antagonists; Polycystic Ovary Syndrome | 1987 |
5 other study(ies) available for naltrexone and Insulin Sensitivity
| Article | Year |
|---|---|
Low-dose naltrexone rescues inflammation and insulin resistance associated with hyperinsulinemia.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; Hyperinsulinism; Inflammation; Insulin Resistance; Male; Mice; Naltrexone; RAW 264.7 Cells; Sirtuin 1; Transcription Factor RelA | 2020 |
Improving efficacy of the adjustable gastric band: studies of the use of adjuvant approaches in a rodent model.
Topics: Adipose Tissue, Brown; Animals; Anti-Obesity Agents; Blood Glucose; Body Composition; Body Fat Distribution; Body Temperature; Bupropion; Diet, High-Fat; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Eating; Energy Metabolism; Gastroplasty; Glucose Intolerance; Injections, Subcutaneous; Insulin Resistance; Laparoscopy; Male; Naltrexone; Obesity; Physical Conditioning, Animal; Rats, Sprague-Dawley; Thermogenesis; Thyroxine; Weight Loss | 2017 |
[Effect of chronic blockade of the opiodergic receptor on insulin resistance in a hyperandrogenic woman].
Topics: Acanthosis Nigricans; Administration, Oral; Adult; Blood Glucose; Female; Gonadotropins; Humans; Hyperandrogenism; Insulin; Insulin Resistance; Naltrexone; Testosterone; Time Factors | 1994 |
Opiate antagonist treatment of ovarian failure.
Topics: Adolescent; Adult; Amenorrhea; Blood Glucose; Endorphins; Female; Follicle Stimulating Hormone; Glucose Tolerance Test; Humans; Hypothalamus; Insulin; Insulin Resistance; Luteinizing Hormone; Middle Aged; Naltrexone; Ovarian Diseases; Pregnancy | 1993 |
Role of opioid tone in the pathophysiology of hyperinsulinemia and insulin resistance in polycystic ovarian disease.
Topics: Adolescent; Adult; C-Peptide; Female; Glucose; Humans; Hyperinsulinism; Insulin Resistance; Naltrexone; Opioid Peptides; Polycystic Ovary Syndrome | 1998 |